(S)-MALT1-IN-5

• UNSPSC Description:

  (S)-MALT1-IN-5 is a potent inhibitor of MALT1 protease. (S)-MALT1-IN-5 inhibits the activity of MALT1 is expected to be able to correct the enhancement of MALT1 activity due to abnormality of T cell receptor signal or B cell receptor signal, and cancer or inflammatory disease caused by MALT1 activity is expected. (S)-MALT1-IN-5 has the potential for the research of MALT1-related diseases (extracted from patent WO2020111087A1, compound 1)[1].

• Target Antigen:

  MALT1

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease;NF-κB

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cancer; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/s-malt1-in-5.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(NC1=C([C@@H](OC)C)C2=NC(C)=CN2N=C1)NC3=CC(Cl)=C(OC(F)F)N=C3

• Molecular Weight:

  426.81

• References & Citations:

  [1]Heterocyclic compound. Patent WO2020111087A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2434602-25-0